Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives
11/29/2000EP1054688A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275161A Monoclonal antibody 3-6-A specific to surface of dendritic cells among the peripheral blood leukocytes
11/29/2000CN1275132A Treatmet of obesity
11/29/2000CN1275130A Human gene HSPCO18 (CBCCFE10)
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
11/29/2000CN1274729A New tumor necrosin mutein and its preparation and application
11/29/2000CN1274728A New human protein and its code sequence, preparation and application
11/29/2000CN1274727A New human protein and its code sequence, preparation and application
11/29/2000CN1274726A Human tobule related protein 1A/1B light chain 3 and its code sequence, preparation and application
11/29/2000CN1058993C Prepn. and use of molecular chimera for treatment of cancer
11/29/2000CN1058972C Prodn. of human growth hormone by using animal mamma as raw material
11/28/2000US6153814 Polypeptide compositions toxic to lepidopteran insects and methods for making same
11/28/2000US6153741 DNA methylation gene from plants
11/28/2000US6153740 Polynucleotide sequence coding a transport polypeptide; for the treatment of human tumors and viral diseases; antitumor agents
11/28/2000US6153732 Kit for detecting analyte indicative of type II collagen resorption in vivo
11/28/2000US6153730 Detoxification by heparin binding, heparin neutralization, endotoxin binding, endotoxin neutralization or bactericidal activity
11/28/2000US6153729 A polypeptide for drug delivering a variety of therapeutic and diagnostic agents, such as transcription regulatory factors of the cell
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153600 Administering, in vivo, at or around the site of the solid tumor, a nucleic acid which encodes an ip-10 polypeptide, for inhibiting a solid tumor in a mammal
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153585 Arylsulfonanilide derivatives
11/28/2000US6153583 OP-3 induced morphogenesis
11/28/2000US6153581 Drug for recovering renal function
11/28/2000US6153580 For generating an immune response in host
11/28/2000US6153579 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
11/28/2000US6153442 Compounds comprise two biotinyl radicals connected by a chain of atoms; the bis-biotin is conjugated to a member of a specific binding pair; for use in an assay for an analyte
11/28/2000US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153431 Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153429 Cell lines useful for in vitro assay for indentification of carcinogens
11/28/2000US6153423 Nucleotide sequence coding a heart polypeptide; for diagnosis, prevention, and treatment of heart, neuronal, immunological, and tumor defects; antitumor agents
11/28/2000US6153421 Nucleotide sequences which code microorganismal genome; for development of viricides; for preventing mammalian viral infection
11/28/2000US6153409 Simple, efficient method by adding baculovirus vector which codes for protein of interest and green fluorescent protein to insect larvae food, feeding to insect larvae, monitoring for gene expression, harvesting, recovering protein
11/28/2000US6153408 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
11/28/2000US6153407 Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153404 Regulatory sequence linked to sequence coding for a heterologous polypeptide; for controlled/inducible gene expression in recombinant system
11/28/2000US6153403 Lysosomal-associated multispanning membrane protein, LAPTM5 and nucleic acid encoding LAPTM5
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153395 ICAM-related protein
11/28/2000US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153382 Viral growth inhibition
11/28/2000US6153380 In vitro mehtod by introducing library of random nucleic acids into cells to produce peptides, screening for cells exhibiting an altered phenotype; better intracellular localization of peptides
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153377 Synthetic DNA derived recombinant HIV antigens
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153199 Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
11/28/2000US6153195 Method of delivering drugs to cells specific for an HL-60 lectin
11/28/2000US6153194 Borrelia burgdorferi outer membrane proteins
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6153183 A modified human interleukin-3 polypeptide, comprises the replacement of 6 to about 44 residues at positions 17-118 of native interleukin-3 by other amino acids with the proviso that asparagine at position 101 and lysine at position 116
11/28/2000US6153182 Lymphotactin as an adjuvant
11/28/2000US6152358 Bioluminescent novelty items
11/28/2000CA2308259A1 Method for assaying the function of flaa1 and wbpm
11/28/2000CA2305716A1 Method for assay of wbpm
11/28/2000CA2182970C Lyophilized stem cell factor formulations
11/28/2000CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants
11/28/2000CA2074681C Genetic engineering process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA2032253C 5-lipoxygenase activating protein
11/27/2000CA2310218A1 A composition and method for treating bacterial infection
11/23/2000WO2000070665A2 Long lasting anti-angiogenic peptides
11/23/2000WO2000070351A2 Protein-protein interactions and methods for identifying them
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070089A1 Cdx2 is downstream mediator of apc tumor suppressor activity
11/23/2000WO2000070077A2 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 5 (mOATP5) AND SCREENING METHODS THEREOF
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070075A1 STREPTOCOCCUS PNEUMONIAE yerS
11/23/2000WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/23/2000WO2000070069A1 Acquired resistance genes in plants
11/23/2000WO2000070066A1 The maize rs324 promoter and methods for use thereof
11/23/2000WO2000070061A2 Senescence-related promoters
11/23/2000WO2000070059A2 Signal transduction genes and methods of use
11/23/2000WO2000070055A1 Rnp originating in paramyxovirus
11/23/2000WO2000070054A1 Pathogen-resistant grape plants
11/23/2000WO2000070053A1 Transgenic plants exhibiting an altered flowering time
11/23/2000WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070050A1 Compositions and methods for the treatment of immune related diseases